Technologies

IBC Addresses Critical Supply Shortages of Ac-225 with Commercially Available Molecular Recognition Technology™ (MRT™) for Highly Selective Separation of Ac-225

  • by

​ Strong clinical potential of radioligand therapy is evident from recently published clinical trial results Global supply shortage of Ac-225 is impacting supply to clinical trials Demand is increasing for high-purity isotopes to conduct and scale… Read More »IBC Addresses Critical Supply Shortages of Ac-225 with Commercially Available Molecular Recognition Technology™ (MRT™) for Highly Selective Separation of Ac-225